This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The Health Stocks in Motion

Shares of Apria Healthcare (AHG) were among the worst-performing health-related stocks Friday, falling 16% after the company warned that full-year results would fall below expectations.

The company, which provides home respiratory therapy, home infusion therapy and home medical equipment, now expects earnings of between $1.68 and $1.72 a share on sales growth of 2% to 3%. Previously, the company said that it would earn $1.90 to $1.95 a share and post sales growth of 5% to 6%. Analysts polled by Thomson First Call had been expecting earnings of $1.90 a share on sales of $1.52 billion. Apria blamed the shortfall on a third-quarter slowdown in its durable medical equipment, respiratory medications and infusion therapy segments. Shares were trading down $4.90 to $26.66.

Natural Health Trends (BHIP) fell 25% after the company announced that its president, Mark Woodburn, and Terry LaCore, chief executive at the company's Lexxus International subsidiary, would no longer serve as officers of the company. The two were relieved of their duties because of "their failure to cooperate with an ongoing investigation conducted by the company's audit committee," the company said.

The men, both of whom resigned from their board positions, will now be employed as global managing directors, with Woodburn serving in operations and LaCore serving in business development. The company also announced the appointment of Robert Hesse as interim chief executive officer. Shares were trading down $3.95 to $11.60.

Shares of Wyeth (WYE) traded actively after the company said its third-quarter earnings would be better than Wall Street expectations. The drugmaker expects earnings in the mid- to upper-70-cent range, which is above the 72 cents a share that analysts had been expecting. A year ago, the company earned 76 cents a share.

Looking ahead, Wyeth reiterated its full-year pro forma earnings outlook of $2.80 to $2.90 a share, but said that if current business trends continue, earnings would "likely reach or even exceed the upper end of the range." Analysts had been expecting earnings of $2.92 a share. For 2006, the company expects year-over-year pro forma earnings growth that will be in the high single-digit range. Analysts are looking for 2006 earnings of $3.12 a share. Shares were trading down 33 cents to $45.74.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs